Peri‑operative Management of Cannabis Use in Hip Surgery
Consensus and Timing Recommendations
- The British Journal of Anaesthesia guideline states that for the 1‑ to 6‑day window before surgery there is no consensus recommendation on whether to wean or stop cannabis, creating a clinical “gray zone.” [1][2]3
- When surgery is scheduled more than 7 days away, the guideline advises considering weaning or cessation of cannabis to potentially reduce analgesic tolerance, interference with processed EEG monitoring, and postoperative nausea/vomiting. [1][2]
- If surgery is planned within 24 hours, the guideline recommends not attempting weaning or cessation because abrupt discontinuation may precipitate acute withdrawal during the peri‑operative period. [1][2]
Withdrawal Risks
- Cannabis withdrawal syndrome (CWS) typically peaks within the first week after cessation, presenting with irritability, anxiety, sleep disturbance, and possible worsening of chronic pain. 3
- The expert panel warns that tapering or stopping cannabis within a day of surgery increases the risk of CWS, which can complicate the peri‑operative course by aggravating pain and anxiety. 3
Pre‑operative Assessment
- Patients should be screened for baseline cannabis consumption, with “significant use” defined as >1.5 g/day smoked cannabis, >300 mg/day CBD oil, or >20 mg/day THC oil. This helps gauge withdrawal risk and plan management. [1][2]
Intra‑operative Considerations
- Processed EEG monitoring (e.g., bispectral index or entropy) may be affected by cannabis, so extra attention to signal quality is advised. [4][3]
- Additional prophylaxis for postoperative nausea and vomiting (PONV) should be considered, as cannabis users may have an altered risk profile. [4][3]
- Anesthesiologists may need to target a greater depth of anesthesia during induction and maintenance because cannabis can modify anesthetic requirements. [4][3]
Post‑operative Management
- Maintain heightened vigilance for CWS in the immediate postoperative period to identify and treat withdrawal symptoms promptly. [4][3]
- Referral to an acute pain service is advisable, since patients may exhibit analgesic tolerance and require intensified postoperative analgesia. [4][3]
- Cannabis use is not a contraindication to the use of NSAIDs, opioids, regional anesthesia, ketamine, gabapentinoids, dexmedetomidine, or acetaminophen. [4][3]
Special Considerations (CBD vs. THC)
- Use of CBD‑dominant products (CBD:THC > 10:1) is associated with a lower risk of withdrawal compared with THC‑dominant formulations. [1][2]
- Do not wean CBD while continuing THC, as this may exacerbate adverse effects of THC. 3
General Principle
- The guideline emphasizes that surgery should never be delayed solely for cannabis weaning or re‑evaluation, because the risks of postponing necessary hip surgery outweigh concerns about cannabis timing. 4
Perioperative Cannabis Management
Preoperative Considerations
- For high-dose cannabis users, the British Journal of Anaesthesia recommends tapering or cessation to begin at least 7 days before elective surgery, though surgery should never be delayed for cannabis weaning 5, 6
- Reducing cannabis consumption may decrease risks of analgesic tolerance, cannabis withdrawal syndrome, interference with EEG-based anesthesia monitoring, and postoperative nausea/vomiting 5
- The British Journal of Anaesthesia suggests targeting initial reduction to just below threshold doses, with weaning collaborative with the patient's tolerance guiding the taper rate 6, 7
- Significant cannabis use is defined as exceeding 1.5 g/day of smoked cannabis, 300 mg/day CBD oil, or 20 mg/day THC oil, according to the British Journal of Anaesthesia 5, 6, 7, 8
Intraoperative Management
- The British Journal of Anaesthesia recommends giving extra consideration to processed EEG monitoring as cannabis may interfere with readings, and considering additional PONV prophylaxis 5
- The British Journal of Anaesthesia suggests planning for potentially greater depth of anesthesia during induction and maintenance, and considering regional anesthesia when not contraindicated 5, 6, 7
Postoperative Care
- The British Journal of Anaesthesia advises maintaining vigilance for cannabis withdrawal syndrome, and considering acute pain service referral 5
- The Society for Perioperative Assessment and Quality Improvement recommends that elective surgery should preferably not occur within 3 days of cannabis use, with a 2-week abstinence period ideal to reduce airway irritability in smokers 9
Important Considerations
- The British Journal of Anaesthesia states that surgery should never be delayed for cannabis re-evaluation or weaning, as the risks of delaying necessary surgery outweigh concerns about cannabis use 6, 7
- The British Journal of Anaesthesia warns against aggressive CBD weaning without expert guidance, as CBD may mask adverse THC effects, and never weaning CBD while maintaining THC consumption 5